Table D7Effectiveness of different statins for a 65-year-old patient with a starting cholesterol level of 6 mmol/l

StatinRR on CHDRR on CVA (stroke/PAD/TIA)
Simvastatin 40 mg0.5290.915
Simvastatin 80 mg0.4790.903
Atorvastatin 80 mg0.3860.876

From: Appendix D, The cost-effectiveness of treating to target compared to a fixed-dose statins in patients with Type 2 diabetes

Cover of Type 2 Diabetes
Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update).
NICE Clinical Guidelines, No. 66.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.